|
Volumn 255, Issue SUPPL. 6, 2008, Pages 22-27
|
Immunosuppression in clinical practice : AAApproaches to individualized therapy
|
Author keywords
Azathioprine; Cyclophosphamide; Methotrexate; Mitoxantrone; Pharmacogenetics
|
Indexed keywords
AZATHIOPRINE;
BETA INTERFERON;
CYCLOPHOSPHAMIDE;
GLATIRAMER;
GLUCOCORTICOID;
INTERFERON BETA SERINE;
METHOTREXATE;
METHYLPREDNISOLONE;
MITOXANTRONE;
NATALIZUMAB;
PIXANTRONE;
RAZOXANE;
IMMUNOSUPPRESSIVE AGENT;
ALLERGIC ENCEPHALOMYELITIS;
ALOPECIA;
AMENORRHEA;
AZOOSPERMIA;
BONE MARROW SUPPRESSION;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DRUG DOSE ESCALATION;
DRUG MECHANISM;
DRUG RESPONSE;
DYSPEPSIA;
HEADACHE;
HEMORRHAGIC CYSTITIS;
HEREDITY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER TOXICITY;
METABOLISM;
MULTIPLE SCLEROSIS;
NAUSEA;
NONHUMAN;
PHARMACOGENETICS;
PRIORITY JOURNAL;
REVIEW;
RHEUMATOID ARTHRITIS;
RISK BENEFIT ANALYSIS;
STOMATITIS;
CLASSIFICATION;
IMMUNOLOGY;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MULTIPLE SCLEROSIS;
|
EID: 64149123239
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-008-6005-y Document Type: Review |
Times cited : (4)
|
References (46)
|